The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...
Dexcom G6 is the first Continuous Glucose Monitoring (CGM) System to be listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a leader in ...
BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM), is happy to share that people with type 1 diabetes who are ...
On Wednesday, medical device manufacturer Dexcom finally delivered its direct-to-Apple Watch functionality for the G7 CGM. Here's how it works. A constant glucose monitor (CGM) has historically worked ...
The FDA has approved San Diego, California-based Dexcom for a Bluetooth-enabled continuous glucose monitor (CGM), called the G5 Mobile CGM system. Correction: A previous version of this article ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Medicare covers home-use glucometers under Original Medicare Part B’s durable medical equipment (DME) benefit. Medicare generally covers fingerstick monitors and FDA-approved continuous glucose ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The best glucose meter can make a huge difference in your diabetes care. Whether you’re prediabetic, type ...
Nov 16 (Reuters) - DexCom Inc said it has received approval to calibrate its seven-day continuous glucose monitoring system using any blood glucose meter cleared by the Food and Drug Administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback